Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Arlett

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacology & Therapeutics|November 27, 1999
Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effectsA Cave, P Arlett, E Lee
The British Journal of Clinical Practice|March 1, 1997
Open access fundholding endoscopy in the private sectorJ Martin, P Arlett, G Holdstock
Archives of Disease in Childhood|March 22, 2001
A novel scheme for the reporting of adverse drug reactionsA Clarkson, E Ingleby, I Choonara, et al.
British Journal of Clinical Pharmacology|October 24, 2002
St John's wort (Hypericum perforatum): drug interactions and clinical outcomesL Henderson, Q Y Yue, C Bergquist, et al.
Clinical Pharmacology and Therapeutics|March 2, 2012
Drug-induced PML: a global agenda for a global challengeM Vinhas de Souza, B Keller-Stanislawski, K Blake, et al.
Clinical Pharmacology and Therapeutics|December 22, 2016
Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspectiveR Anton, M Haas, P Arlett, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|November 27, 1999
Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effectsA Cave, P Arlett, E Lee
The British Journal of Clinical Practice|March 1, 1997
Open access fundholding endoscopy in the private sectorJ Martin, P Arlett, G Holdstock
Archives of Disease in Childhood|March 22, 2001
A novel scheme for the reporting of adverse drug reactionsA Clarkson, E Ingleby, I Choonara, et al.
British Journal of Clinical Pharmacology|October 24, 2002
St John's wort (Hypericum perforatum): drug interactions and clinical outcomesL Henderson, Q Y Yue, C Bergquist, et al.
Clinical Pharmacology and Therapeutics|March 2, 2012
Drug-induced PML: a global agenda for a global challengeM Vinhas de Souza, B Keller-Stanislawski, K Blake, et al.
Clinical Pharmacology and Therapeutics|December 22, 2016
Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspectiveR Anton, M Haas, P Arlett, et al.
Pageof 1